A new monoclonal anti-A. Culture supernatants with the performance of hyperimmune human reagents.
By proper selection for good growth and high avidity, we have prepared a new anti-A monoclonal antibody producing cell line that gives culture supernatants as potent as US-licensed commercial hyperimmune human reagents and which meet USA FDA standards without the need for concentration. The production and use of this reagent is cost effective and makes it a candidate to replace conventional anti-A typing reagents.
D000017:ABO Blood-Group System / Q000276:immunology*; D000818:Animals; D000911:Antibodies, Monoclonal; D001788:Blood Grouping and Crossmatching / Q000379:methods*; D003362:Cost-Benefit Analysis; D006801:Humans; D006825:Hybridomas / Q000276:immunology; D051379:Mice
D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal